发明名称 |
Paclitaxel treatment regimen for metastatic melanoma |
摘要 |
The invention relates generally to a method of using paclitaxel in a specific Q4Dx3 schedule and dosage for patients with malignant melanoma. The low risk-benefit ratio of this specific schedule provides a method for therapeutic use for all stages of severity of disease ranging from local resectable tumor to diagnosed widespread malignant melanoma. |
申请公布号 |
AU5364201(A) |
申请公布日期 |
2001.10.30 |
申请号 |
AU20010053642 |
申请日期 |
2001.04.18 |
申请人 |
NAPRO BIOTHERAPEUTICS, INC. |
发明人 |
LARRY HELSON |
分类号 |
A61K31/337;A61P35/00 |
主分类号 |
A61K31/337 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|